Neuberger Berman Group’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-19,162
Closed -$856K 1997
2021
Q4
$856K Sell
19,162
-110
-0.6% -$5.29K ﹤0.01% 1404
2021
Q3
$961K Sell
19,272
-2,075
-10% -$108K ﹤0.01% 1320
2021
Q2
$1.15M Sell
21,347
-1,350
-6% -$67.8K ﹤0.01% 1300
2021
Q1
$1.04M Sell
22,697
-4,650
-17% -$223K ﹤0.01% 1307
2020
Q4
$1.34M Sell
27,347
-2,100
-7% -$100K ﹤0.01% 1186
2020
Q3
$1.31M Sell
29,447
-3,200
-10% -$135K ﹤0.01% 1146
2020
Q2
$1.25M Sell
32,647
-915
-3% -$37K ﹤0.01% 1094
2020
Q1
$1.38M Buy
+33,562
New +$1.61M ﹤0.01% 1029

Other funds holding ELAT

Neuberger Berman Group's ELAT Position: Q1 2022 in Review

Neuberger Berman Group sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2022, closing a stake of 19,162 shares — an estimated $856K sold.

Neuberger Berman Group first reported a position in ELAT in Q1 2020 and held it in 8 quarters. The position peaked at $1.38M in Q1 2020. 37 funds tracked by Wall St. Rank hold ELAT as of Q1 2022.

  • Neuberger Berman Group reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2022 after selling out during the quarter.
  • Neuberger Berman Group sold 19,162 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2022, an estimated $856K.
  • Neuberger Berman Group first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2020 and held it in 8 quarters.
  • Neuberger Berman Group's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $1.38M in Q1 2020.
  • 37 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2022.

Based on Neuberger Berman Group's 13F filing for Q1 2022, filed 13 May 2022.